Dr Reddys Labs

Dr Reddy's Laboratories' Q2 net profit soars 77% to Rs 504 cr; revenue up 7% to Rs 3,798 cr

Commenting on the results, Dr Reddy's Lab's co-chairman and CEO, G V Prasad said, "I am encouraged by our performance and progress in the second quarter. Our continuous focus on execution, operational efficiency and cost optimization are showing results.

Dr Reddy's Labs Q1 net profit increases nearly eight-fold to Rs 456 cr on operational efficiencies, forex gains

Shares of Dr Reddys Laboratories closed at Rs 2,134.55 per scrip on BSE, up 2.19 percent from its previous close.

Vedanta, Dr Reddy's Labs shares fall up to 4% after Sensex rejig came into effect today

Under the Sensex reconstitution, Vedanta has entered the benchmark index, while Dr Reddy's Labs has exited the index

Sensex, Nifty rides on auto sales numbers, ends week on a high

Strengthening for the third day, the benchmark Sensex went up 162 points to end at 31,892.23, a three-week high, while the Nifty closed short of 10,000

Sensex, Nifty make marginal gains, Infosys closes up too

Sensex settled up 33 points, or 0.11 percent, at 31,291.85 while Nifty ended at 9,765.55, up 11.20 points

LIC sells 2% stake in Dr Reddy's Lab

Life Insurance Corporation (LIC) sold 2.13 per cent stake in Dr Reddy's Laboratories from January 10 to May 10 through open market, according to a BSE filing by DRL.

Dr Reddys Q4 net up 67% at Rs 571 crore

Drug firm Dr Reddy's Laboratories today reported a 66.58 percent rise in its net profit to Rs 570.89 crore for the quarter ended March 31, 2013 mainly on account of robust sales across all segments.

Lowe Lintas bags over 100 accounts in 15 months